ImmuCell
ICCC
ICCC
22 hedge funds and large institutions have $7.34M invested in ImmuCell in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $8.86M → $7.34M (-$1.51M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$223K | |
| 2 | +$144K | |
| 3 | +$77K | |
| 4 |
Renaissance Technologies
New York
|
+$72.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.75K |
Top Sellers
| 1 | -$975K | |
| 2 | -$364K | |
| 3 | -$119K | |
| 4 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.42K |